New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung ...

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices ...

A new data cut of a trial pitting ivonescimab, a bispecific antibody, against Merck’s Keytruda showed the new drug helped ...

Rasonque may help people with advanced pancreatic cancer live longer while offering a new treatment option in addition to ...

Personalized cancer treatment aims to match patients with therapies based on specific features of their cancer, but tumors ...

Cancer treatment has undergone significant changes as scientific knowledge and medical technology have advanced. Treatme ...

Cancer treatment is changing rapidly. For many patients, treatment is no longer a single course of chemotherapy or radiation, ...

In a small clinical trial of the drug daraxonrasib (Rasonque), tumours shrank in more than 30% of participants with the most common form of lung cancer, non-small cell lung cancer. Each participant ...

A new Yale study has identified a promising therapeutic avenue for atherosclerosis, a condition caused by inflammation and ...

Andrew Ko, who led UCSF's trials of daraxonrasib based on discovery science, tells what to know about the medicine, the ...

From today, the Australian government will expand Pharmaceutical Benefit Scheme (PBS) access to the drug Keytruda for three ...

Advances in early screening mammography and new, targeted treatments have reduced overall mortality and recurrence in breast cancer. Yet, despite these advances in traditional treatment options, some ...